Zi Michael Miao

811 total citations
21 papers, 341 citations indexed

About

Zi Michael Miao is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Zi Michael Miao has authored 21 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 14 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Zi Michael Miao's work include Heart Failure Treatment and Management (18 papers), Diabetes Treatment and Management (13 papers) and Cardiovascular Function and Risk Factors (9 papers). Zi Michael Miao is often cited by papers focused on Heart Failure Treatment and Management (18 papers), Diabetes Treatment and Management (13 papers) and Cardiovascular Function and Risk Factors (9 papers). Zi Michael Miao collaborates with scholars based in United Kingdom, United States and Netherlands. Zi Michael Miao's co-authors include Brian Claggett, Scott D. Solomon, John J.V. McMurray, Akshay S. Desai, Muthiah Vaduganathan, Pardeep S. Jhund, Carolyn S.P. Lam, Adrian F. Hernandez, Sanjiv J. Shah and Silvio E. Inzucchi and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Zi Michael Miao

20 papers receiving 337 citations

Peers

Zi Michael Miao
Comparison fields: 5 of 42
  • Cardiology and Cardiovascular Medicine 255
  • Endocrinology, Diabetes and Metabolism 172
  • Pulmonary and Respiratory Medicine 59
  • Surgery 50
  • Molecular Biology 48
Replace Mikhail Kosiborod with:
Mikhail Kosiborod United States
Arjun Pandey Canada
Eugenia Belotti Italy
Shohei Kishi Japan
Ian J. Kulac United States
Eva A. Karpanou Greece
Krishmita Siwakoti United States
Nisha Suda United States
Tamaz Shaburishvili United States
Itaru Hisauchi Japan
Mikhail Kosiborod United States View profile →
Citations per field, relative to Zi Michael Miao
Zi Michael Miao · 1×
Citations per year, relative to Zi Michael Miao
Zi Michael Miao · 1×

Countries citing papers authored by Zi Michael Miao

Since Specialization
Citations

This map shows the geographic impact of Zi Michael Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi Michael Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi Michael Miao more than expected).

Fields of papers citing papers by Zi Michael Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi Michael Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi Michael Miao. The network helps show where Zi Michael Miao may publish in the future.

Co-authorship network of co-authors of Zi Michael Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Zi Michael Miao. A scholar is included among the top collaborators of Zi Michael Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi Michael Miao. Zi Michael Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Efficacy and Safety of Vutrisiran in Transthyretin Amyloid Cardiomyopathy Across the Age Spectrum: The HELIOS-B Trial
2025 ·European Journal of Heart Failure ·(unknown), Zi Michael Miao, Brian Claggett, Pablo García‐Pavía, Francesco Cappelli, Emre Aldinc, Julian D. Gillmore, Scott Solomon, (unknown)
0
2
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI
2024 ·Journal of the American College of Cardiology ·Douglas L. Mann, Johny Nicolas, Brian Claggett, Zi Michael Miao, Christopher B. Granger, Prafulla Kerkar, Lars Køber, Eldrin F. Lewis, John J.V. McMurray, Aldo P. Maggioni, Julio Núñez, Mpiko Ntsekhe, Jean‐Lucien Rouleau, David Sim, Scott D. Solomon, Philippe Gabríel Steg, Peter van der Meer, Eugene Braunwald, Marc A. Pfeffer, Roxana Mehran
6
3
Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial
2024 ·Circulation ·Mark C. Petrie, Jean L. Rouleau, Brian Claggett, Karola Jering, Peter van der Meer, Lars Køber, Zi Michael Miao, Eldrin F. Lewis, Christopher B. Granger, Carmine G. De Pasquale, Douglas L. Mann, Philippe Gabríel Steg, Aldo P. Maggioni, Offer Amir, Marty Lefkowitz, Eugene Braunwald, Scott D. Solomon, John J.V. McMurray, Marc A. Pfeffer
1
4
Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease
2024 ·European Heart Journal ·John W. Ostrominski, Mats Christian Højbjerg Lassen, Brian Claggett, Zi Michael Miao, Silvio E. Inzucchi, Kieran F. Docherty, Akshay S. Desai, Pardeep S. Jhund, Lars Køber, Piotr Ponikowski, Marc S. Sabatine, (unknown), Felipe A. Martínez, Rudolf A. de Boer, Adrian F. Hernandez, Sanjiv J. Shah, Magnus Petersson, (unknown), John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan
3
5
Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure
2024 ·Circulation ·Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Zi Michael Miao, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, Meike Brinker, James Lay‐Flurrie, Prabhakar Viswanathan, Markus F. Scheerer, Andrea Lage, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, John J.V. McMurray, Scott D. Solomon
25
6
Tricuspid Regurgitation and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction
2024 ·JACC Heart Failure ·Marianna Adamo, Marco Metra, Brian Claggett, Zi Michael Miao, Rafael Díaz, G. Michael Felker, John J.V. McMurray, Scott D. Solomon, Tor Biering‐Sørensen, (unknown), Stephen B. Heitner, Stuart Kupfer, Fady I. Malik, John R. Teerlink
10
7
Cardiovascular-Kidney-Metabolic Overlap in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
2024 ·Journal of the American College of Cardiology ·John W. Ostrominski, Brian Claggett, Zi Michael Miao, Finnian R. Mc Causland, Inder S. Anand, Akshay S. Desai, Pardeep S. Jhund, Carolyn S.P. Lam, Marc A. Pfeffer, Bertram Pitt, Faı̈ez Zannad, Michael R. Zile, (unknown), James Lay‐Flurrie, Prabhakar Viswanathan, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan
17
8
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial
2023 ·Circulation ·John W. Ostrominski, Muthiah Vaduganathan, Senthil Selvaraj, Brian Claggett, Zi Michael Miao, Akshay S. Desai, Pardeep S. Jhund, Mikhail Kosiborod, Carolyn S.P. Lam, Silvio E. Inzucchi, Felipe A. Martínez, Rudolf A. de Boer, Adrian F. Hernandez, Sanjiv J. Shah, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon
11
9
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
2023 ·European Heart Journal ·Muthiah Vaduganathan, Robert J. Mentz, Brian Claggett, Zi Michael Miao, Ian J. Kulac, Jonathan H. Ward, Adrian F. Hernandez, David A. Morrow, Randall C. Starling, Eric J. Velazquez, Kristin Williamson, Akshay S. Desai, Shelley Zieroth, Martin Lefkowitz, John J.V. McMurray, Eugene Braunwald, Scott D. Solomon
56
10
Renal and Blood Pressure Effects of Dapagliflozin in Recently Hospitalized Patients with Heart Failure with mildly reduced or Preserved Ejection Fraction: Insights from the DELIVER Trial
2023 ·European Journal of Heart Failure ·Safia Chatur, Jonathan W. Cunningham, Muthiah Vaduganathan, Finnian R. Mc Causland, Brian Claggett, Akshay S. Desai, Zi Michael Miao, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon
15
11
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
2023 ·European Heart Journal ·Safia Chatur, Muthiah Vaduganathan, Brian Claggett, Orly Vardeny, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer, Carolyn S.P. Lam, Mikhail Kosiborod, Sanjiv J. Shah, Felipe A. Martínez, Silvio E. Inzucchi, Adrian F. Hernandez, Tariq Haddad, Sumeet S. Mitter, Zi Michael Miao, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon
31
12
Influence of Background Medical Therapy on Efficacy and Safety of Dapagliflozin in Patients with Heart Failure with Improved Ejection Fraction in the DELIVER Trial
2023 ·European Journal of Heart Failure ·Maria Pabón, Brian Claggett, Xiaowen Wang, Zi Michael Miao, Safia Chatur, Ankeet S. Bhatt, Muthiah Vaduganathan, James C. Fang, Akshay S. Desai, Pardeep S. Jhund, Felipe A. Martínez, Rudolf A. de Boer, Mikhail Kosiborod, Carolyn S.P. Lam, Sanjiv J. Shah, Adrian F. Hernandez, John J.V. McMurray, Scott D. Solomon, Orly Vardeny
6
13
Effect of Dapagliflozin on Health Status and Quality of Life Across the Spectrum of Ejection Fraction: Participant-Level Pooled Analysis from the DAPA-HF and DELIVER Trials
2023 ·European Journal of Heart Failure ·Ankeet S. Bhatt, Mikhail Kosiborod, Muthiah Vaduganathan, Brian Claggett, Zi Michael Miao, Ian J. Kulac, Carolyn S.P. Lam, Adrian F. Hernandez, Felipe A. Martínez, Silvio E. Inzucchi, Sanjiv J. Shah, Rudolf A. de Boer, Pardeep S. Jhund, Akshay S. Desai, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon
12
14
Effects of Dapagliflozin on Heart Failure Hospitalizations According to Severity of Inpatient Course: Insights from DELIVER and DAPA-HF
2023 ·European Journal of Heart Failure ·Safia Chatur, Toru Kondo, Brian Claggett, Kieran F. Docherty, Zi Michael Miao, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan
5
15
Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status
2023 ·JACC Heart Failure ·Alexander Peikert, Parag Goyal, Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Zi Michael Miao, Orly Vardeny, Mikhail Kosiborod, Akshay S. Desai, Pardeep S. Jhund, Carolyn S.P. Lam, Silvio E. Inzucchi, Felipe A. Martínez, Rudolf A. de Boer, Adrian F. Hernandez, Sanjiv J. Shah, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon
13
16
Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
2023 ·JACC Heart Failure ·John W. Ostrominski, Jorge Thierer, Brian Claggett, Zi Michael Miao, Akshay S. Desai, Pardeep S. Jhund, Mikhail Kosiborod, Carolyn S.P. Lam, Silvio E. Inzucchi, Felipe A. Martínez, Rudolf A. de Boer, Adrian F. Hernandez, Sanjiv J. Shah, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan
23
17
Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
2022 ·JACC Heart Failure ·Peder L. Myhre, Muthiah Vaduganathan, Brian Claggett, Zi Michael Miao, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Akshay S. Desai, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon
32
18
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial
2022 ·European Heart Journal ·Scott D. Solomon, Brian Claggett, Zi Michael Miao, Rafael Díaz, G. Michael Felker, John J.V. McMurray, Marco Metra, Ramón Corbalán, Gerasimos Filippatos, Assen Goudev, Mareev VIu, Pranas Šerpytis, Thomas Suter, Mehmet Birhan Yılmaz, Faı̈ez Zannad, Stuart Kupfer, Stephen B. Heitner, Fady I. Malik, John R. Teerlink
7
19
Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
2022 ·JACC Heart Failure ·Senthil Selvaraj, Muthiah Vaduganathan, Brian Claggett, Zi Michael Miao, James C. Fang, Orly Vardeny, Akshay S. Desai, Sanjiv J. Shah, Carolyn S.P. Lam, Felipe A. Martínez, Silvio E. Inzucchi, Rudolf A. de Boer, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon
18
20
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial
2022 ·European Heart Journal ·Marco Metra, Matteo Pagnesi, Brian Claggett, Rafael Díaz, G. Michael Felker, John J.V. McMurray, Scott D. Solomon, Diana Bonderman, James C. Fang, Cândida Fonseca, Eva Gonçalvesová, Jonathan G. Howlett, Jing Li, Eileen O’Meara, Zi Michael Miao, Siddique Abbasi, Stephen B. Heitner, Stuart Kupfer, Fady I. Malik, John R. Teerlink
16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mikhail Kosiborod Breakdown of academic impact, for papers by Arjun Pandey Breakdown of academic impact, for papers by Eugenia Belotti Breakdown of academic impact, for papers by Shohei Kishi Breakdown of academic impact, for papers by Ian J. Kulac Breakdown of academic impact, for papers by Eva A. Karpanou Breakdown of academic impact, for papers by Krishmita Siwakoti Breakdown of academic impact, for papers by Nisha Suda Breakdown of academic impact, for papers by Tamaz Shaburishvili Breakdown of academic impact, for papers by Itaru Hisauchi
Rankless by CCL
2026